Table 2 Basic characteristics of included studies
Study | Year | Design | Group | Sample size | Age (years) | Gender (M/F) | Lenke classification | Fusion Levels | Preoperative Cobb (°) | Preoperative TK (°) | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|
Miyanji | 2015 | Retrospective | MISS | 23 | 16.8 ± 0.4 | 3/20 | 1 (20); 2 (2); 4 (1) | 10.2 | 56.7 ± 1.6 | 20.5 ± 2.1 | 24.0 |
PSF | 23 | 16.4 ± 0.3 | 4/19 | 1 (12); 2 (8); 3 (3) | 12.2 | 58.1 ± 1.6 | 22.6 ± 3.4 | 24.0 | |||
Sarwahi | 2016 | Retrospective | MISS | 7 | 15.1 ± 3.2 | 1/6 | 1 (4); 2 (1); 5 (2) | 10.0 ± 1.8 | 48.3 ± 8.3 | 20.7 ± 11.0 | 29.2 ± 2.3 |
PSF | 15 | 15.4 ± 2.1 | 2/13 | 1 (6); 2 (1); 4 (4); 5 (2); 6 (2) | 12.3 ± 1.6 | 46.7 ± 3.3 | 24.0 ± 9.8 | 37.0 ± 7.4 | |||
Zhu | 2017 | Retrospective | MISS | 15 | 16.5 ± 1.6 | 2/13 | 5 (15) | 4.9 ± 0.5 | 48.3 ± 4.2 | 20.2 ± 6.1 | 27.1 ± 4.0 |
PSF | 30 | 15.1 ± 1.7 | 3/27 | 5 (30) | 5.7 ± 0.5 | 50.9 ± 5.4 | 16.5 ± 6.8 | 32.9 ± 3.5 | |||
Urbanski | 2019 | Retrospective | MISS | 4 | 15.5 ± 2.1 | 4/0 | 5 (4) | 6.5 ± 0.9 | 57.3 ± 10.6 | 23.6 ± 7.6 | NA |
PSF | 4 | 21.3 ± 10.0 | 3/1 | 5 (4) | 5.8 ± 0.4 | 47.0 ± 7.8 | 37.0 ± 16.1 | NA | |||
Si | 2020 | Retrospective | MISS | 64 | 13.2 ± 1.7 | 20/44 | 1 (18); 2 (12); 3 (19); 4 (15) | 8.4 ± 2.3 | 50.7 ± 8.8 | 29.2 ± 9.4 | 31.2 ± 4.7 |
PSF | 48 | 14.6 ± 1.9 | 14/34 | 1 (21); 2 (11); 3 (12); 4 (4) | 6.2 ± 2.6 | 48.0 ± 8.4 | 28.7 ± 7.1 | 32.3 ± 6.3 | |||
Yang | 2021 | Retrospective | MISS | 24 | 15.0 ± 1.9 | 0/24 | 1 (17); 3 (4); 5 (2); 6 (1) | 12.3 ± 1.4 | 60.8 ± 9.4 | 35.0 ± 9.2 | 116.4 ± 0.0 |
PSF | 25 | 14.0 ± 1.5 | 0/25 | 1 (13); 2 (1); 3 (7); 4 (1); 5 (1); 6 (2) | 12.1 ± 1.5 | 62.1 ± 12.9 | 26.5 ± 12.1 | 55.2 ± 2.4 | |||
Sarwahi | 2021 | Retrospective | MISS | 192 | 15.0 ± 1.9 | 25/167 | NA | 11.3 ± 2.2 | 55.7 ± 9.0 | 24.7 ± 12.7 |  > 24.0 |
PSF | 293 | 15.0 ± 2.4 | 66/227 | NA | 11.7 ± 2.2 | 53.3 ± 11.2 | 25.3 ± 12.7 |  > 24.0 |